The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDWF.L Regulatory News (DWF)

  • There is currently no data for DWF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consideration Shares admitted to trading

4 Mar 2020 09:47

RNS Number : 9855E
DWF Group PLC
04 March 2020
 

DWF Group plc

("DWF", the "Group" or the "Company")

 

  LEI: 213800O9QREOHTOGQ266

Consideration Shares admitted to trading

 

 

Wednesday 4 March 2020

Further to its announcement on 2 March 2020 regarding the completion of the acquisition of Mindcrest Inc. DWF is pleased to announce that 5,028,726 ordinary shares in the capital of DWF have today been admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market.

For further information:

DWF Group plc

Andrew Leaitherland

Chris Stefani

James Igoe

+44(0)20 7280 8929

Finsbury

Ed Simpkins

Charles O'Brien

+44(0)20 7251 3801

 

Stifel

Stewart Wallace

Tom Marsh

+44 (0)20 7710 7612

 

Jefferies

Max Jones

William Brown

+44 (0)20 7548 4576

 

Zeus

Dominic King

Dan Bate

+44 (0) 20 3829 5607

 

Notes to Editors

About DWF

DWF is a global legal business providing Complex, Managed and Connected Services, operating from 33 key locations with approximately 4,300 people. The Company became the first Main Market Premium Listed legal business on the London Stock Exchange in March 2019. DWF recorded revenue of £272.4 million in the year ended 30 April 2019. For more information visit: www.dwf.law 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSSLSULESSELD
Date   Source Headline
14th Mar 202312:08 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSDWF reappointed to RSA defence panel
2nd Feb 20234:00 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
30th Jan 20232:29 pmRNSDirectorate Change
24th Jan 20237:00 amRNSHolding(s) in Company
16th Jan 202312:22 pmRNSDirector/PDMR Shareholding
10th Jan 202312:32 pmRNSHolding(s) in Company
9th Jan 20237:00 amRNSDWF reappointed to Aviva core legal panel
3rd Jan 20231:16 pmRNSIssue of Consideration Shares &Total Voting Rights
15th Dec 202212:48 pmRNSHolding(s) in Company
9th Dec 202211:13 amRNSDirector/PDMR Shareholding
8th Dec 20229:37 amRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSHalf Year Results
6th Dec 20227:00 amRNSDWF completes transaction with Whitelaw Twining
29th Nov 20224:36 pmRNSPrice Monitoring Extension
7th Nov 20227:00 amRNSDWF to acquire leading Canadian law firm
13th Oct 202211:42 amRNSHolding(s) in Company
4th Oct 202212:10 pmRNSDirector Declaration
28th Sep 20224:24 pmRNSResults of the Annual General Meeting
28th Sep 20227:00 amRNSAGM Statement
15th Sep 20227:00 amRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSDWF expands its Connected Services capability
6th Sep 20227:00 amRNSDWF appoints Chief Growth & Strategy Officer
31st Aug 202211:33 amRNSDirector/PDMR Shareholding
17th Aug 20224:14 pmRNSAnnual report and accounts and Notice of AGM
4th Aug 20224:00 pmRNSDirector/PDMR Shareholding
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
22nd Jul 20221:25 pmRNSDirector/PDMR Shareholding
21st Jul 20227:00 amRNSFull-year results for the year ended 30 April 2022
27th May 20227:00 amRNSAppointment of Joint Corporate Broker
26th May 20227:05 amRNSDWF agrees Hong Kong affiliation
26th May 20227:00 amRNSFY22 Trading Statement
21st Mar 20227:00 amRNSDWF announces new associations
21st Jan 202211:44 amRNSDWF Legal Services Panel Appointment
22nd Dec 202110:24 amRNSDirector Declaration
9th Dec 202110:26 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSDWF Group plc announces global ESG Strategy
9th Dec 20217:00 amRNSHalf-year Report
2nd Dec 202110:35 amEQSHardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021)
8th Nov 20212:05 pmEQSHardman & Co Research : Hardman & Co Video Event | DWF Group plc - Investor Forum
3rd Nov 20215:07 pmEQSHardman & Co Video Event | DWF Group plc Investor Forum
28th Sep 20213:34 pmRNSResults of the Annual General Meeting
28th Sep 20217:00 amRNSAGM Trading Update and notice of results
27th Aug 20215:15 pmRNSDirector/PDMR Shareholding
24th Aug 20215:04 pmRNSAGM and other meetings
23rd Aug 202111:29 amRNSHolding(s) in Company
17th Aug 20215:17 pmRNSDirector/PDMR Shareholding
10th Aug 20217:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.